Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2012
06/21/2012WO2012051111A3 Human oncostatin m antibodies and methods of use
06/21/2012WO2012047294A3 Antibodies directed against hla-b27 homodimers and methods and uses thereof in diagnosis and therapy
06/21/2012US20120157667 Methods Of Producing Humanized Non-Human Mammals
06/21/2012US20120157664 Method for the production of domain antibodies
06/21/2012US20120157663 Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same
06/21/2012US20120157662 Means and methods for producing high affinity antibodies
06/21/2012US20120157522 B. Anthracis Prevention and Treatment: Mutant B. Anthracis Lacking Luxs Activity and Furanone Inhibition of Growth, AI-2 Quorum Sensing, and Toxin Production
06/21/2012US20120157513 Small Peptide Expression System in Mammalian Cells
06/21/2012US20120157393 Biopolymer, implant comprising it and uses thereof
06/21/2012US20120157384 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/21/2012US20120156726 Velocity factor
06/21/2012US20120156725 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors
06/21/2012US20120156724 Humanized anti-cd47 antibody
06/21/2012US20120156723 Protein glycosylation
06/21/2012US20120156722 Tumor Suppressor Gene
06/21/2012US20120156721 Chemically modified mutant serine hydrolases show improved catalytic activity and chiral selectivity
06/21/2012US20120156720 Compositions and Methods of Producing Enterokinase in Yeast
06/21/2012US20120156719 Method for universal enzymatic production of bioactive peptides
06/21/2012US20120156672 Novel stringent selectable markers
06/21/2012US20120156295 Antibiotic compounds
06/21/2012US20120156282 Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
06/21/2012US20120156254 Recombinant laminin-521
06/21/2012US20120156236 Neisseria meningitidis antigens and compositions
06/21/2012US20120156217 Novel EGFR-Binding Molecules and Immunoconjugates Thereof
06/21/2012US20120156198 Antibodies against IL-18R1 and uses thereof
06/21/2012US20120156195 Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus
06/21/2012US20120156186 Non-cytotoxic protein conjugates
06/21/2012CA2821888A1 Method for producing proteins
06/21/2012CA2821791A1 High-yield peptide antibiotics producing strain, preparation method and use thereof
06/21/2012CA2821268A1 Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof
06/21/2012CA2820151A1 Process for production of protein
06/21/2012CA2815286A1 Cry1i proteins and genes for insect control
06/20/2012EP2465520A2 Epitope sequences
06/20/2012EP2464739A2 Methods in cell cultures, and related inventions, employing certain additives
06/20/2012EP2075258B1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same
06/20/2012EP1810979B1 STABILIZED HUMAN IgG4 ANTIBODIES
06/20/2012EP1487479B1 Mutant glycoproteins
06/20/2012EP1463942B2 Methods for purifying protein
06/20/2012EP1452541B1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
06/20/2012CN102505034A Method for preparing active polypeptide from corn protein powder
06/20/2012CN102505033A Method for preparing lactoferricin and method for applying lactoferricin in bacterial inhibition of foods
06/20/2012CN102504936A Process for preparing barley germ oil and low molecular weight peptide by solid enzymolysis-CO2 (carbon dioxide) supercritical extraction
06/20/2012CN102504789A Lipopetide biosurfactant oil extraction agent for improving extraction rate of crude oil
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102504022A Proinsulin containing protecting lysine and preparation method for insulin by utilizing proinsulin
06/20/2012CN102504019A Method for separating cecropin antimicrobial peptides
06/20/2012CN102504017A Novel Enterococcus and Streptococcus strains and bacteriocins
06/20/2012CN102499269A Composite attractant of bactrocera dorsalis hendel
06/20/2012CN101948893B Method for producing nisin by continuous fermentation
06/20/2012CN101838628B Method for producing L-amino acids using bacteria belonging to the genus escherichia
06/20/2012CN101824225B Tussah silk peptide-glutin blend film and preparation method
06/20/2012CN101659975B Preparation method of HRPII protein monoclonal antibody of plasmodium falciparum
06/20/2012CN101643501B Novel antibiotic and nucleotide sequence, preparation method and application thereof
06/19/2012US8205259 Adaptive behavioral intrusion detection systems and methods
06/19/2012US8202973 Method for the production of vitamin K-dependent proteins
06/19/2012US8202716 Thermophilic and thermoacidophilic biopolymer-degrading genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
06/19/2012US8202704 Trichoderma genes
06/19/2012US8202700 Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule
06/19/2012US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/19/2012CA2478012C Internalizing anti-cd74 antibodies and methods of use
06/19/2012CA2474108C Novel fluorescent proteins from aequorea coerulscens and methods for using same
06/19/2012CA2393975C Insect poison allergens with reduced ige reactivity and method for producing the same
06/19/2012CA2390898C Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues
06/19/2012CA2311166C Nucleic acids involved in the responder phenotype and applications thereof
06/19/2012CA2241726C Genes and gene products related to werner's syndrome
06/14/2012WO2012078878A2 TNF-α BINDING PROTEINS
06/14/2012WO2012078852A2 Algae biomass fractionation
06/14/2012WO2012077649A1 Human monoclonal antibody
06/14/2012WO2012077643A1 IMMUNOLOGICAL cofilin-1 PROTEIN MEASUREMENT METHOD
06/14/2012WO2012075570A1 Bioactive peptides and proteins containing bioactive peptides, their uses and processes for making the same
06/14/2012US20120151611 method of producing an antibody using a cancer cell
06/14/2012US20120151610 Soluble "heavy-chain only" antibodies
06/14/2012US20120149880 Nucleic Acid Cassette For Producing Recombinant Antibodies
06/14/2012US20120149874 Method for preparing recombinant glycoproteins with high sialic acid content
06/14/2012US20120149762 Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof
06/14/2012US20120149636 Modified Leptin Polypeptides and Their Uses
06/14/2012US20120149590 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore
06/14/2012US20120149120 Chimeric protein, method for manufacturing the same, nano-sensor in which the chimeric protein is fixed, and application thereof
06/14/2012US20120149089 Animal product free system and process for purifying a botulinum toxin
06/14/2012US20120149085 Fusion proteins containing recombinant cytotoxic rnases
06/14/2012US20120149064 Filamentous Fungi With Impaired PTRB Activity For Altered Protein Production
06/14/2012US20120149063 Process for the culturing of cells
06/14/2012US20120149062 High Purity Lipopeptides
06/14/2012US20120149061 Modified Antibody Compositions, Methods of Making and Using Thereof
06/14/2012US20120149060 Nucleic Acids for Cloning and Expressing Multiprotein Complexes
06/14/2012US20120149028 Detection and visualization of the cell cycle in living cells
06/14/2012US20120149010 Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
06/14/2012US20120148625 Anti-bacterial Vaccine Compositions
06/14/2012US20120148618 Multiple variants of meningococcal protein nmb1870
06/14/2012US20120148616 Neisseria meningitidis antigens and compositions
06/14/2012US20120148607 Anti c-met antibodies
06/14/2012US20120148601 Bacterial superantigen vaccines
06/14/2012US20120148600 Anti-CD79B Antibodies and Immunoconjugates and Methods of Use
06/14/2012US20120148599 Methods and compositions for neural disease immunotherapy
06/14/2012US20120148597 Human monoclonal antibodies to ctla-4
06/14/2012US20120148596 Molecular conjugates comprising human monoclonal antibodies to dendritic cells
06/14/2012US20120148592 Neutralizing anti-ccl20 antibodies
06/14/2012US20120148590 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
06/14/2012US20120148582 Engineered anti-il-23r antibodies
06/14/2012US20120148580 Methods for identification of sites for igg conjugation
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 1125